Received a live vaccine within  days of the first dose of study medication
Administration of a live vaccine within  days prior to first dose of study drug
Received a live vaccine within  days prior to first dose of study drug
Has received a live vaccine within  days prior to the first dose of study therapy
Has received a live-virus vaccine within  days prior to first dose of study medication.
Has received a live vaccine within  days prior to the first dose of study therapy
Have received a live vaccine within  days before the first dose of study treatment.
Has received a live vaccine within  days prior to first dose of study drug.
Received a vaccine within  days of first dose
Received a live vaccine within  days of the first dose of treatment.
Received a live vaccine =<  days prior to registration
Vaccinations with a live vaccine within  days prior to start of treatment or need for live vaccine at any time during study treatment.
Has received a live vaccine ?  days prior to study registration
Has received a live vaccine within  days prior to the initiation of lymphodepletion.
Has received a live vaccine within  days prior to registration
Has received a live attenuated vaccine within  days before the first dose of study drug
Has received a live vaccine within  days prior to the first dose of study drug
Received live vaccine within  days prior to enrollment
Has received a live vaccine within  days prior to the first dose of study treatment.
Live vaccine ?  weeks prior to enrollment
Received any live vaccine within the last  days
Patients who have received a live vaccine within  days prior initiation of the systemic regimen
Received a live vaccine within  weeks prior to the start of study drug
Patients who have received a live vaccine within  days prior initiation of the systemic regimen
Has received a live vaccine within  days of first study procedure (apheresis)
Patients who have received live, attenuated vaccine within  days prior to the first dose of PD- inhibitor.
Has received a live vaccine within  days prior to the first dose of study drug
Received a live vaccine within  days prior to start of study treatment
Received a live vaccine =<  days prior to registration
Administration of a live vaccine within  weeks of first dose of study drug
Has received a live vaccine within  days prior to first dose
Patients who have received a live vaccine within  days prior to the first dose of pembrolizumab
Received live vaccine within  days prior to enrollment
Received a live vaccine =<  days prior to registration
Has received a live vaccine within  days prior to registration
Has received a live attenuated vaccine within  days before the first dose of study drug
Subjects must not have received a live vaccine within  days prior to the first dose of study medication
Received a live vaccine within  days of first protocol treatment
Have received a live vaccine within  days before the first dose of study treatment.
Received live vaccine =<  days prior to registration
Has received a live vaccine within  days prior to the first dose of study drug
Received a live vaccine within  days prior to first dose of study drug
Patient has received a live vaccine within  weeks prior to the first dose of treatment
Administration of a live vaccine within  weeks of first dose of study drug
Have received any live vaccine within  days prior to first study drug administration.
History of receiving a live vaccine  days prior to study treatment.
Has received a live vaccine within  days prior to the first dose of study treatment
Received a live vaccine within  days prior to the first dose of study treatment.
Received live vaccine within  days prior to enrollment
Patient has received a live vaccine within  days prior to first dose
Live vaccine within  days prior to treatment initiation.
Patients who have received a live vaccine within  days prior to the radiation therapy
Has received a live vaccine within  days prior to the first protocol treatment
Received any live vaccine =<  days prior to registration
Received a live vaccine within  week prior to the first dose of study treatment
Has received a live vaccine within  days prior to transplant admission
Has received a live vaccine within  days of the first dose of study therapy
Has received a live vaccine within  days prior to first dose of study drug.
Received a live vaccine within  days prior to the first dose of study medication
Live vaccine use within  days of first dose of study medication.
Has received a live virus vaccine within  days of allocation.
Has received a live virus vaccine within  days of randomization.
Received live vaccine within  days prior to enrollment
Has taken any prohibited medications that are listed in the protocol within  days of the first dose of study treatment. Subject has received or will receive a live vaccine within  days before the first administration of study treatment
Subject has received a live virus vaccine within the previous  weeks.
Patients planning for a live vaccine
Has received a live vaccine within  days prior to first dose.
Received or will receive a live vaccine within  days prior to first dose of study drug
Received a live vaccine within  days prior to first dose of study drug
Live vaccine ?  weeks prior to start of conditioning regimen
Received a live vaccine within  days of the first dose of study medication
Treatment with live vaccine within  days prior to the first dose of study medication are not eligible
Has received a live vaccine within  days prior to the first dose of study drug
Has received a live vaccine within  days prior to the radiation therapy
Has received a live vaccine within  days prior to the first dose of study drug
Has received a live vaccine within  days prior to the first dose of study treatment
Has received a live vaccine within  days prior to the first dose of study treatment
Has received a live vaccine within  days of the first dose of study treatment.
Live vaccine within  days prior to registration.
Has received a live vaccine within  days prior to first dose of study therapy
Patient who have received a live vaccine within  days prior to cycle  day 
Have received a live vaccine within  days before the first dose of study treatment
Participant has received a live vaccine within  weeks (less than  days) prior to CD
Subject has received a live vaccine within  weeks prior to CD
Received live, attenuated vaccine within  days prior to the first dose of mogamulizumab;
Participant has received a live vaccine within  weeks prior to screening
Received live vaccine within  days prior to enrollment
Received a live vaccine within  days prior to day 
Has received a live vaccine within  days prior to first dose
Has received a live vaccine within  days prior to the first dose of study therapy
Has received a live vaccine within  days prior to the first dose of study treatment
Has received a live vaccine within  days prior to the first dose of study treatment.
Live vaccine ?  weeks prior to enrollment
Has received a live-virus vaccine within  days prior to the first dose of study treatment
Received a live viral vaccine within  months prior to the first dose of study drug.
Received live vaccine within  days prior to enrollment.
Has received a live vaccine within  days prior to randomization.
Received live vaccine within  days prior to enrollment.
Has received a live vaccine within  days prior to first dose of study drug.